Clinical Trial Update: Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial compares olanzapine to megestrol acetate for treating loss of appetite in patients with advanced cancer; the study status is ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Anorexia
• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm

Drugs mentioned

• Megace (megestrol acetate)
• Zyprexa (olanzapine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Advanced Malignant Solid Neoplasm, Anorexia | Phase 3 | Status: ACTIVE_NOT_RECRUITING